Best TWAS P=1.08e-15 · Best GWAS P=3.59e-19 conditioned to 2.94e-05
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | GATAD2A | 0.13 | 0.30 | lasso | 7 | 0.29 | 2.4e-35 | -5.6 | 5.6 | 2.6e-08 | -0.35 | 1.00 | 0.00 | FALSE |
2 | GTEx | Artery Tibial | MAU2 | 0.07 | 0.05 | lasso | 4 | 0.05 | 1.3e-04 | -5.8 | -5.8 | 7.7e-09 | 0.38 | 0.45 | 0.23 | FALSE |
3 | GTEx | Cells Transformed fibroblasts | ATP13A1 | 0.14 | 0.06 | lasso | 5 | 0.05 | 2.2e-04 | -8.0 | -8.0 | 1.1e-15 | 0.93 | 0.19 | 0.56 | TRUE |
4 | GTEx | Cells Transformed fibroblasts | GATAD2A | 0.07 | 0.00 | lasso | 4 | 0.00 | 8.1e-01 | -5.7 | -6.9 | 4.6e-12 | 0.72 | 0.07 | 0.31 | FALSE |
5 | GTEx | Muscle Skeletal | MAU2 | 0.09 | 0.04 | lasso | 4 | 0.05 | 5.1e-06 | -5.0 | 6.1 | 1.1e-09 | -0.59 | 0.99 | 0.01 | FALSE |
6 | GTEx | Spleen | ATP13A1 | 0.16 | 0.01 | lasso | 5 | 0.02 | 9.7e-02 | -5.6 | -6.4 | 1.6e-10 | 0.35 | 0.08 | 0.07 | TRUE |
7 | GTEx | Whole Blood | TMEM161A | 0.06 | 0.00 | enet | 2 | 0.00 | 1.4e-01 | -5.7 | 5.7 | 1.5e-08 | -0.39 | 0.19 | 0.09 | FALSE |
8 | GTEx | Whole Blood | GATAD2A | 0.06 | 0.02 | lasso | 9 | 0.03 | 1.7e-03 | -6.0 | -6.3 | 2.7e-10 | 0.63 | 0.36 | 0.53 | FALSE |
9 | ROSMAP | Brain Pre-frontal Cortex | ATP13A1 | 0.10 | 0.07 | lasso | 5 | 0.06 | 1.3e-08 | -5.9 | 6.0 | 1.8e-09 | -0.78 | 0.14 | 0.85 | FALSE |
10 | YFS | Blood | GATAD2A | 0.09 | 0.14 | blup | 365 | 0.14 | 7.5e-44 | -5.6 | -5.3 | 1.5e-07 | 0.38 | 1.00 | 0.00 | FALSE |
11 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | GATAD2A | 0.02 | 0.02 | lasso | 1 | 0.02 | 2.1e-03 | -5.6 | -5.6 | 1.8e-08 | 0.38 | 0.09 | 0.04 | FALSE |
12 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | HAPLN4 | 0.05 | 0.07 | lasso | 2 | 0.06 | 1.1e-07 | -6.0 | -6.2 | 4.6e-10 | 0.48 | 0.99 | 0.01 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | TM6SF2 | 0.04 | 0.03 | blup | 35 | 0.03 | 2.5e-04 | -5.4 | -6.4 | 1.7e-10 | 0.76 | 0.22 | 0.44 | FALSE |
14 | The Cancer Genome Atlas | Brain Lower Grade Glioma | KIAA0892 | 0.03 | 0.01 | lasso | 7 | 0.02 | 6.3e-03 | -6.0 | 5.9 | 3.5e-09 | -0.41 | 0.06 | 0.18 | FALSE |
15 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | GMIP | 0.07 | 0.00 | blup | 43 | 0.02 | 2.3e-02 | -6.2 | -6.0 | 1.7e-09 | 0.49 | 0.02 | 0.39 | FALSE |
16 | The Cancer Genome Atlas | Prostate Adenocarcinoma | GATAD2A | 0.04 | 0.03 | lasso | 2 | 0.03 | 2.9e-04 | -5.6 | -5.9 | 3.1e-09 | 0.52 | 0.24 | 0.39 | FALSE |
17 | The Cancer Genome Atlas | Thyroid Carcinoma | HAPLN4 | 0.08 | 0.06 | blup | 37 | 0.09 | 1.8e-09 | -5.9 | -5.7 | 1.0e-08 | 0.33 | 1.00 | 0.00 | FALSE |
18 | The Cancer Genome Atlas | Thyroid Carcinoma | KIAA0892 | 0.04 | 0.04 | blup | 43 | 0.02 | 4.1e-03 | -6.0 | 6.2 | 5.6e-10 | -0.43 | 0.53 | 0.05 | FALSE |
19 | The Cancer Genome Atlas | Thyroid Carcinoma | TM6SF2 | 0.05 | 0.04 | blup | 34 | 0.05 | 2.8e-05 | -5.4 | -5.8 | 5.2e-09 | 0.71 | 0.29 | 0.55 | FALSE |